LEXXW vs ORCL · rev $705.9K vs P/E 31, rev $67.36B
Lexaria Bioscience Corp (LEXXW) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Michael D. Sicilia.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
LEXXW currently screens at market cap $33.8M. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the LEXXW and ORCL stock pages for the full models.
Not investment advice.